Arkolith/Insider Trading/ARTV/Form 4

GC Corp.

10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed May 28, 2026
Net Buying
Open-Market Buys
$16.5M
Open-Market Sells
$0
Net Open-Market Flow
$16.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Buy(P)1.1M$11.52$12.5M4.4M
May 11, 2026Buy(P)347K$11.52$4.0M1.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001931382-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML